{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:52:48Z","timestamp":1788983568542,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd013520","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000}}],"reference-count":170,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013520.pub2","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T12:59:09Z","timestamp":1646312349000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis"],"prefix":"10.1002","volume":"2022","author":[{"given":"Su-Hsun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Aurora CO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute; The Johns Hopkins University School of Medicine; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sueko M","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Aurora CO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ren","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute; The Johns Hopkins University School of Medicine; Baltimore Maryland USA"},{"name":"Orthopedics; Columbia University Irving Medical Center; New York, New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Leslie","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Aurora CO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genie","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene C","family":"Kuo","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute; The Johns Hopkins University School of Medicine; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"594-8","DOI":"10.4103\/ijo.IJO_1352_18","article-title":"Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis","volume":"67","author":"Bhargava","year":"2019","journal-title":"Indian Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0002|cit2","unstructured":"To compare safety and efficacy of topical Tacrolimus (0.03%) and dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000033956"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"070","DOI":"10.24966\/OCR-8887\/100070","article-title":"Modified treatment for epidemic keratoconjunctivitis","volume":"7","author":"Elwan","year":"2020","journal-title":"Journal of Ophthalmology & Clinical Research"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0004|cit4","unstructured":"Modified treatment for epidemic keratoconjunctivitis (EKC) clinicaltrials.gov\/ct2\/show\/NCT04169919"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/ICO.0000000000002589","article-title":"Corticosteroids versus cyclosporine for subepithelial infiltrates secondary to epidemic keratoconjunctivitis: a prospective randomized double-blind study","volume":"40","author":"Gouider","year":"2021","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0006|cit6","unstructured":"Treatment of corneal infiltrates secondary to epidemic keratoconjunctivitis clinicaltrials.gov\/ct2\/show\/NCT04376970"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"e686-92","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0008|cit8","unstructured":"The effect of iodine compounds on patients with adenoviral keratoconjunctivitis rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000036821"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10384-020-00788-3","article-title":"Comparative study of topical regimen for adenoviral kearoconjunctivitis by 0.1% fluorometholone with and without polyvinyl alcohol iodine","volume":"65","author":"Matsuura","year":"2021","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0010|cit10","first-page":"98-100","article-title":"Comparison of topical steroid drops with cyclosporin eye drops in the treatment of corneal subepithelial infiltrates in epidemic keratoconjunctivitis","volume":"14","author":"Rafe","year":"2020","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0011|cit11","unstructured":"Ricciardelli G Giannaccare G Di Zazzo A Coassin M Scorcia V Romano MR Efficacy and tolerability of polyvinylpyrrolidone-iodine 0.6% treatment in adenoviral keratoconjunctivitis: a prospective randomized controlled study Eye (Lond) 10.1038\/s41433-020-01344-6"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0012|cit12","first-page":"S579","article-title":"Ganciclovir effects in adenoviral keratoconjunctivitis [ARVO Abstract 3111-B253]","volume":"42","author":"Tabbara","year":"2001","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"899-906","DOI":"10.1055\/s-2008-1057579","article-title":"The effects of topical steroids in epidemic kerato-conjunctivitis","volume":"176","author":"Trauzettel-Klosinski","year":"1980","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"3","key":"10.1002\/14651858.CD013520.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"216-21","DOI":"10.1097\/00003226-199305000-00006","article-title":"A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis","volume":"12","author":"Ward","year":"1993","journal-title":"Cornea"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.11261\/iryo1946.20.131","article-title":"Effect of ABOB [N'-N'-anhydro-bis (beta-hydroethyl) biguanide hydrochloride] eye drops on epidemic keratoconjunctivitis","volume":"20","author":"Abe","year":"1966","journal-title":"Iryo"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0016|cit16","unstructured":"A pilot study: the effect of in-office irrigation with 5% povidone-iodine to reduce the duration of adenoviral conjunctivitis www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12613000460707"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0017|cit17","unstructured":"OKG-0301 for the treatment of acute adenoviral conjunctivitis anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12619000177156"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"429-32","DOI":"10.1016\/0002-9394(84)90125-9","article-title":"Interferon treatment of adenoviral conjunctivitis","volume":"98","author":"Adams","year":"1984","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/eye.2017.4","article-title":"Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis","volume":"31","author":"Asena","year":"2017","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0020|cit20","first-page":"453","article-title":"Eficacia de la magnetoterapia en pacientes con queratitis viral","volume":"17","author":"Basulto Quir\u00f3s","year":"2013","journal-title":"Archivo M\u00e9dico Camag\u00fcey"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2020.1766510","article-title":"The treatment models for adenoviral keratoconjunctivitis in the childhood population","volume":"Jul 9","author":"Bekmez","year":"2020","journal-title":"Ocular Immunology and Inflammation"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0022|cit22","first-page":"44","article-title":"Epidemic viral conjunctivitis in geriatric patients: homeopathic treatment","volume":"13","author":"Borrel Garcia","year":"1998","journal-title":"Pesquisa Homeop\u00e1tica"},{"issue":"12","key":"10.1002\/14651858.CD013520.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1007\/s10792-020-01503-4","article-title":"The role of ozonized oil and a combination of tobramycin\/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial","volume":"40","author":"Cagini","year":"2020","journal-title":"International Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0024|cit24","unstructured":"Efficacy and security in the treatment of conjunctivitis by adenovirus treated with opopatadine (Opatanol\u00ae) and artificial drops (Acuolens\u00ae) vs pranoprofen (Oftalar\u00ae) and artificial drops (Acuolens\u00ae) www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2007-000059-33"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0025|cit25","unstructured":"A phase 2, randomized, double-masked, placebo-controlled, parallel-assignment study of topical N-Chlorotaurine (NCT) formulated with ammonium chloride administered for 10 days in patients with epidemic adenoviral keratoconjunctivitis (EKC) www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2007-002101-50"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0026|cit26","unstructured":"Study of the comparative efficacy of two different treatments used in acute conjunctivitis by adenovirus: ganciclovir 0.15% and saline solution 0.9% www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2014-002319-41-ES"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0027|cit27","unstructured":"Treatment of eye infection caused by Adenovirus www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2017-004614-25-FI"},{"issue":"629","key":"10.1002\/14651858.CD013520.pub2-BIB0028|cit28","first-page":"56","article-title":"Effectiveness of homeopathic treatment in epidemic viral conjunctivitis of the polyclinic Juan B. Contreras in 1997","volume":"73","author":"Gonnzalez Garcia","year":"2004","journal-title":"La Homeopat\u00eda de M\u00e9xico"},{"issue":"11","key":"10.1002\/14651858.CD013520.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.oftale.2019.07.009","article-title":"Iodine povidone. A new paradigm in the treatment of adenoviral conjunctivitis?","volume":"94","author":"Gonzalez-Martin-Moro","year":"2019","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/00003226-199609000-00018","article-title":"Treatment of adenoviral conjunctivitis with topical cidofovir","volume":"15","author":"Gordon","year":"1996","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0031|cit31","first-page":"ARVO Abstract 1","article-title":"Topical treatment of adenoviral keratoconjunctivitis with cidofovir and cyclosporin a. A clinical pilot study","volume":"41","author":"Hillenkamp","year":"2000","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"10","key":"10.1002\/14651858.CD013520.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"1487-91","DOI":"10.1001\/archopht.119.10.1487","article-title":"Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study","volume":"119","author":"Hillenkamp","year":"2001","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"845-50","DOI":"10.1016\/s0161-6420(02)00992-2","article-title":"The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study","volume":"109","author":"Hillenkamp","year":"2002","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00132578-200210000-00010","article-title":"The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis\u2014a controlled clinical pilot study","volume":"3","author":"Hillenkamp","year":"2002","journal-title":"Evidence-Based Eye Care"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0035|cit35","first-page":"200","article-title":"The treatment of adenoviral keratoconjunctivitis","volume":"46","author":"Kasparov","year":"1991","journal-title":"Oftalmologicheskii Zhurnal"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"36-40","DOI":"10.1001\/archopht.1970.00990040038010","article-title":"Corneal infiltrates in epidemic keratoconjunctivitis. Response to double-blind corticosteroid therapy","volume":"84","author":"Laibson","year":"1970","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD013520.pub2-BIB0037|cit37","first-page":"23","article-title":"Treatment with human alpha (leukocyte) IFN in epidemic haemorrhagic conjunctivitis","volume":"1","author":"Limonta Vidal","year":"1984","journal-title":"Interfer\u00f3n y Biotecnolog\u00eda"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"99-102","DOI":"10.5935\/0004-2749.20140025","article-title":"Artificial tears alone versus 0.45% ketorolac tromethamine with artificial tears for the treatment of acute viral conjunctivitis","volume":"77","author":"Lyra","year":"2014","journal-title":"Arquivos Brasileiros de Oftalmologia"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0039|cit39","unstructured":"Artificial tears versus preservative free ketorolac trometamol 0.45% for acute viral conjunctivitis https:\/\/clinicaltrials.gov\/show\/NCT01799863"},{"issue":"11","key":"10.1002\/14651858.CD013520.pub2-BIB0040|cit40","first-page":"1407","article-title":"Trial treatment of viral keratoconjunctivitis","volume":"86","author":"Mergier","year":"1986","journal-title":"Bulletin des Societes d'Ophtalmologie de France"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0041|cit41","first-page":"51-8","article-title":"Clinical Evaluation of NFG Ophthalmic Solution in the Treatment of Viral Conjunctivitis. (Second Report). Evaluation of Clinical Significance by Additional Analysis","volume":"21","author":"Nakajima","year":"1993","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0042|cit42","unstructured":"A clinical trial to study the safety and efficacy of AL-46383A ophthalmic solution for the treatment of adenoviral conjunctivitis www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=1705"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0043|cit43","unstructured":"An evaluation of the efficacy and safety of AL-46383A ophthalmic solution for the treatment of adenoviral conjunctivitis clinicaltrials.gov\/ct2\/show\/study\/NCT00901693"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0044|cit44","unstructured":"Efficacy and safety of GV 550 in acute adenoviral keratoconjunctivitis www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2007-002455-16-DE"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0045|cit45","unstructured":"Efficacy and safety of GV 550 in acute adenovirus keratoconjunctivitis clinicaltrials.gov\/show\/NCT01156025"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0046|cit46","unstructured":"A placebo controlled comparison of topical Zirgan versus Genteal Gel for the treatment of adenovirus conjunctivitis clinicaltrials.gov\/show\/NCT01533480"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0047|cit47","unstructured":"Evaluate the use of ganciclovir gel 0.3% for the treatment of conjunctivitis caused by adenovirus clinicaltrials.gov\/ct2\/show\/NCT01600365"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0048|cit48","unstructured":"Evaluation of the therapeutic efficacy of apd-209 eye drops in treatment of acute phase adenoviral-induced epidemic keratoconjunctivitis (EKC): A randomised, double-masked, placebo-controlled, multi-centre proof-of-concept study www.drks.de\/DRKS00010204"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0049|cit49","unstructured":"Study comparing the efficacy of eye drops containing the substance APD-209 and placebo for the treatment the a viral eye infection called adenoviral-induced epidemic keratoconjunctivitis (EKC) www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2012-005694-31"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0050|cit50","unstructured":"Evaluation of the therapeutic efficacy of apd-209 eye drops in treatment of acute phase adenoviral-induced epidemic keratoconjunctivitis (EKC): A randomised, double-masked, placebo-controlled, multi-centre proof-of-concept study clinicaltrials.gov\/ct2\/show\/NCT01977443"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0051|cit51","unstructured":"A study to find out if study molecule SHP640 (PVP-iodine 0.6% and dexamethasone 0.1%) is effective in comparison to PVP-iodine and placebo for treating conjunctivitis which is an eye disease www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=26247"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0052|cit52","unstructured":"SHP640 in the treatment of adenoviral conjunctivitis www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2016-002439-14-DE"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0053|cit53","unstructured":"Treatment of adenoviral conjunctivitis with SHP640 compared to povidone-iodine (PVP-I) and placebo clinicaltrials.gov\/show\/NCT02998541"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0054|cit54","unstructured":"A study to find out if study molecule SHP640 (PVP-iodine 0.6% and dexamethasone 0.1%) is effective and safe in comparison to placebo for treating conjunctivitis which is an eye disease www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2019\/04\/018758"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0055|cit55","unstructured":"Treatment of adenoviral conjunctivitis with SHP640 compared to placebo clinicaltrials.gov\/ct2\/show\/NCT02998554"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0056|cit56","unstructured":"Efficacy and safety of iota-carrageenan eye drops (NCX-4240) clinicaltrials.gov\/ct2\/show\/NCT03009799"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0057|cit57","unstructured":"To study the efficacy of drug (IVIEW-1201) in the treatment of acute adenoviral conjunctivitis www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2019\/07\/020282"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0058|cit58","unstructured":"Trial to evaluate the efficacy and safety of IVIEW-1201 in acute viral conjunctivitis clinicaltrials.gov\/show\/NCT03749317"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0059|cit59","unstructured":"Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis clinicaltrials.gov\/show\/NCT04041856"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0060|cit60","first-page":"125","article-title":"Treatment of epidemic keratoconjunctivitis by human leukocyte interferon","volume":"24","author":"Negoro","year":"1980","journal-title":"Japanese Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ajo.2018.08.056","article-title":"Randomized, controlled, Phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"197","author":"Cinal","year":"2019","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0062|cit62","first-page":"3602","article-title":"Efficacy and safety of dexamethasone\/povidone-iodine ophthalmic suspension in adenoviral conjunctivitis","volume":"58","author":"Haque","year":"2017","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0063|cit63","unstructured":"FST-100 in the treatment of acute adenoviral conjunctivitis clinicaltrials.gov\/show\/NCT01470664"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"7-15","DOI":"10.1016\/j.ajo.2018.05.012","article-title":"Randomized, controlled, Phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"194","author":"Pepose","year":"2018","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ajo.2019.02.039","article-title":"Randomized, controlled, Phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"205","author":"Pepose","year":"2019","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ajo.2019.03.003","article-title":"Randomized, controlled, Phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for the treatment of adenoviral conjunctivitis","volume":"204","author":"Ramakrishnan","year":"2019","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0067|cit67","unstructured":"FST-100 in the treatment of acute viral conjunctivitis clinicaltrials.gov\/show\/NCT01461954"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"535-44","DOI":"10.2147\/OPTH.S191275","article-title":"A randomized controlled trial of povidone-iodine\/dexamethasone ophthalmic suspension for acute viral conjunctivitis","volume":"13","author":"Pepose","year":"2019","journal-title":"Clinical Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0069|cit69","unstructured":"A trial of topical dexamethasone versus artificial tears for treatment of viral conjunctivitis clinicaltrials.gov\/show\/NCT01481519"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"870-7","DOI":"10.3109\/02713683.2014.964419","article-title":"Dexamethasone\/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial","volume":"40","author":"Pinto","year":"2015","journal-title":"Current Eye Research"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0071|cit71","first-page":"6257","article-title":"Reducing Adenoviral Patient-Infected Days (RAPID) Study: a randomized trial assessing efficacy of one time, in-office application of 5% povidone-iodine in treatment of adenoviral conjunctivitis","volume":"60","author":"Hartwick","year":"2019","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0072|cit72","unstructured":"Reducing Adenoviral Patient Infected Days (RAPID) clinicaltrials.gov\/show\/NCT02472223"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0073|cit73","first-page":"4360","article-title":"Reducing Adenoviral Patient Infected Days (RAPID) Study: association of clinical signs and symptoms with qPCR confirmed adenoviral conjunctivitis","volume":"58","author":"Shorter","year":"2017","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jtos.2019.08.005","article-title":"Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: the Reducing Adenoviral Patient Infected Days (RAPID) study","volume":"17","author":"Shorter","year":"2019","journal-title":"Ocular Surface"},{"issue":"3","key":"10.1002\/14651858.CD013520.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"557-75","DOI":"10.1017\/s0022172400066365","article-title":"Adenovirus type 8 keratoconjunctivitis\u2014an outbreak and its treatment with topical human fibroblast interferon","volume":"96","author":"Reilly","year":"1986","journal-title":"Journal of Hygiene"},{"issue":"574","key":"10.1002\/14651858.CD013520.pub2-BIB0076|cit76","first-page":"2","article-title":"Terapeutica homeopatica en la queratoconjuntivitis epidemica","volume":"64","author":"Rios Varela","year":"1995","journal-title":"Homeopatia de M\u00e9xico"},{"issue":"2-3","key":"10.1002\/14651858.CD013520.pub2-BIB0077|cit77","first-page":"75","article-title":"Interferon and intracellular ocular infections","volume":"57","author":"Romano","year":"1980","journal-title":"Revue Internationale du Trachome et de Pathologie Oculaire Tropicale et Subtropicale"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"95-100","DOI":"10.1089\/jir.1980.1.95","article-title":"Use of human fibroblast-derived (beta) interferon in the treatment of epidemic adenovirus keratoconjunctivitis","volume":"1","author":"Romano","year":"1980","journal-title":"Journal of Interferon Research"},{"issue":"12","key":"10.1002\/14651858.CD013520.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"e201901206","DOI":"10.1590\/s0102-865020190120000006","article-title":"Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis","volume":"34","author":"Santiago","year":"2020","journal-title":"Acta Cir\u00fargica Brasileira"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0080|cit80","first-page":"S260","article-title":"Use of topical ketorolac in viral conjunctivitis: a randomized, placebo-controlled, clinical trial [ARVO Abstract 1368]","volume":"41","author":"Ambati","year":"2000","journal-title":"Investigative Ophthalmology and Vision Science"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"1512-7","DOI":"10.1016\/s0161-6420(00)00177-9","article-title":"A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis","volume":"107","author":"Shiuey","year":"2000","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00132578-200101000-00019","article-title":"A randomized trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis","volume":"2","author":"Shiuey","year":"2001","journal-title":"Evidence-Based Eye Care"},{"issue":"3","key":"10.1002\/14651858.CD013520.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"139-40","DOI":"10.1007\/bf02215650","article-title":"The value of exogenous interferon in adenovirus keratoconjunctivitis. Preliminary results","volume":"218","author":"Sundmacher","year":"1982","journal-title":"Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefe's Archive for Clinical and Experimental Ophthalmology]"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0084|cit84","first-page":"66","article-title":"N-Chlorotaurine\u2014a new endogenous substance for treatment of epidemic keratoconjunctivitis? Clinical trial (phase II) to evaluate its efficacy","volume":"13","author":"Teuchner","year":"1999","journal-title":"Spektrum der Augenheilkunde"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"157-65","DOI":"10.1089\/jop.2005.21.157","article-title":"Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis\u2014a double-blind, randomized, phase-2 clinical trial","volume":"21","author":"Teuchner","year":"2005","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"13","key":"10.1002\/14651858.CD013520.pub2-BIB0086|cit86","first-page":"4649","article-title":"N-chlorotaurine\u2014a new antiviral agent for treatment of adenoviral keratoconjunctivitis tested in a Phase 2b study","volume":"44","author":"Teuchner","year":"2003","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/jop.2011.0082","article-title":"Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study","volume":"28","author":"Trinavarat","year":"2012","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0088|cit88","first-page":"24","article-title":"Epidemic keratoconjunctivitis: usefulness of homeopathic therapy","volume":"10","author":"Varela","year":"1995","journal-title":"Pesquisa Homeop\u00e1tica"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"461-4","DOI":"10.1007\/bf02334177","article-title":"Topical human fibroblast interferon for acute adenoviral conjunctivitis","volume":"225","author":"Wilhelmus","year":"1987","journal-title":"Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefe's Archive for Clinical and Experimental Ophthalmology]"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0090|cit90","unstructured":"A prospective randomised controlled trial of topical steroids versus placebo for viral conjunctivitis www.controlled-trials.com\/ISRCTN50728656"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1299-303","DOI":"10.1136\/bjo.2010.188623","article-title":"A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis","volume":"95","author":"Wilkins","year":"2011","journal-title":"British Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD013520.pub2-BIB0092|cit92","first-page":"42-3","article-title":"Clinical observation of ganciclovir ophthalmic gel in treatment of viral keratitis","volume":"18","author":"Xu","year":"2009","journal-title":"Zhongguo Yaoye [China Pharmaceuticals]"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0093|cit93","unstructured":"Ganciclovir 0,15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis clinicaltrials.gov\/show\/NCT01349452"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1590\/s0004-27492011000600007","article-title":"Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis","volume":"74","author":"Yabiku","year":"2011","journal-title":"Arquivos Brasileiros de Oftalmologia"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0095|cit95","first-page":"809","article-title":"Comparative efficacy of treatment of viral keratitis with ganciclovir ophthalmic gel and acyclovir eye drops","volume":"26","author":"Zhao","year":"2006","journal-title":"Yanke Xin Jinzhan [Recent Advances in Ophthalmology]"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD013520.pub2-BIB0096|cit96","first-page":"10","article-title":"Randomised double-blind trial to control the effectivity of polyvidone iodine 1.25% in viral keratoconjunctivitis epidemica","volume":"218","author":"Lerche","year":"2001","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0097|cit97","unstructured":"The effect of betadine in epidemic keratoconjunctivitis en.irct.ir\/trial\/18262?revision=18262"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0098|cit98","volume-title":"Comparison of the Effect of Betadine .4% and Flucort With Flucort Alone in the Treatment of Epidemic Keratoconjunctivitis [Doctoral Thesis]","author":"Shabazi","year":"2018"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0099|cit99","unstructured":"A controlled trial of topical povidone-iodine to treat EKC en.irct.ir\/trial\/16436"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0100|cit100","unstructured":"Validad MH Seyedpiran G Ahmadi SS Bagherzadeh O Rad KB Sabbaghi H Treatment of epidemic keratoconjunctivitis with a combination of povidone-iodine drops: a controlled randomized study 27th Annual Congress of the Iranian Society of Ophthalmology; 2017 Dec 4-7; Tehran, Iran 2017"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0101|cit101","unstructured":"Comparison of newer treatment versus a standard of care for the treatment of adenoviral conjunctivitis, randomized controlled trial www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=41728"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1017\/ice.2020.404","article-title":"Direct costs and clinical impact of adenovirus genotype 8 conjunctivitis outbreak in a neonatology unit","volume":"42","author":"Angueyra","year":"2021","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013520.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jamaophthalmol.2015.3888","article-title":"Antibiotic resistance among ocular pathogens in the United States: five-year results from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study","volume":"133","author":"Asbell","year":"2015","journal-title":"JAMA Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2018.04.012","article-title":"Molecular epidemiology of human adenovirus infections in Denmark, 2011-2016","volume":"104","author":"Barnadas","year":"2018","journal-title":"Journal of Clinical Virology"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/ICO.0000000000001279","article-title":"Topical tacrolimus for corneal subepithelial infiltrates secondary to adenoviral keratoconjunctivitis","volume":"36","author":"Berisa Prado","year":"2017","journal-title":"Cornea"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.ico.0000170693.13326.fb","article-title":"Adenoviral keratoconjunctivitis in a tertiary care eye clinic","volume":"25","author":"Butt","year":"2006","journal-title":"Cornea"},{"issue":"32","key":"10.1002\/14651858.CD013520.pub2-BIB0107|cit107","first-page":"637","article-title":"Adenovirus-associated epidemic keratoconjunctivitis outbreaks\u2014four states, 2008-2010","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"39","key":"10.1002\/14651858.CD013520.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.15585\/mmwr.mm6639a2","article-title":"Human adenovirus surveillance\u2014United States, 2003-2016","volume":"66","author":"Binder","year":"2017","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0109|cit109","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0110|cit110","unstructured":"A study to find out if study molecule SHP640 (PVP-Iodine 0.6% and dexamethasone 0.1%) is effective in comparison to PVP-Iodine and placebo for treating conjunctivitis which is an eye disease ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=26247&EncHid=&userName=CTRI\/2018\/05\/014027"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjo.67.1.1","article-title":"Clinical and epidemiological features of adenovirus keratoconjunctivitis in London","volume":"67","author":"Darougar","year":"1983","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1056\/NEJM196305092681902","article-title":"Infections due to adenovirus type 8 in the United States II. Community-wide infection with adenovirus type 8","volume":"268","author":"Dawson","year":"1963","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013520.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archopht.1972.01000020260005","article-title":"Adenovirus type 8 infections in the United States. IV. Observations on the pathogenesis of lesions in severe eye disease","volume":"87","author":"Dawson","year":"1972","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD013520.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/ICO.0b013e31815b7d7d","article-title":"Clinical course of epidemic keratoconjunctivitis: evaluation by in vivo confocal microscopy","volume":"27","author":"Dosso","year":"2008","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0115|cit115","unstructured":"Efficacy and safety of GV 550 in acute adenoviral keratoconjunctivitis www.clinicaltrialsregister.eu\/ctr-search\/search?query=2007-002455-16"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0161-6420(89)32749-7","article-title":"Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital","volume":"96","author":"Fitch","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.epirev.a036304","article-title":"Epidemiology of epidemic keratoconjunctivitis","volume":"9","author":"Ford","year":"1987","journal-title":"Epidemiologic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7883\/yoken1952.11.467","article-title":"Epidemiological studies of an outbreak of epidemic keratoconjunctivitis in Ogaki City and its vicinity, Gifu prefecture in 1957","volume":"11","author":"Fukumi","year":"1958","journal-title":"Japanese Journal of Medical Science and Biology"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(81)80754-8","article-title":"Etiology of acute conjunctivitis in children","volume":"98","author":"Gigliotti","year":"1981","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0120|cit120","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"3","key":"10.1002\/14651858.CD013520.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jhin.2007.12.012","article-title":"Nosocomial outbreak of epidemic keratoconjunctivitis accompanying environmental contamination with adenoviruses","volume":"68","author":"Hamada","year":"2008","journal-title":"Journal of Hospital Infection"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00003226-199010000-00013","article-title":"Symblepharon formation in epidemic keratoconjunctivitis","volume":"9","author":"Hammer","year":"1990","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0123|cit123","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7883\/yoken.66.436","article-title":"Molecular epidemiology of human adenoviruses associated with epidemic keratoconjunctivitis in Osaka, Japan, 2001-2010","volume":"66","author":"Hiroi","year":"2013","journal-title":"Japanese Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.03.041","article-title":"Landmark Reprint: Epidemic keratoconjunctivitis (superficial punctate keratitis, keratitis subepithelialis, keratitis maculosa, keratitis nummularis) with a review of the literature and a report of 125 cases","volume":"190","author":"Hogan","year":"2018","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD013520.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0161-6420(88)32994-5","article-title":"Epidemic keratoconjunctivitis and lacrimal excretory system obstruction","volume":"95","author":"Hyde","year":"1988","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9394(02)01701-4","article-title":"A controlled trial of povidone-iodine to treat infectious conjunctivitis in children","volume":"134","author":"Isenberg","year":"2002","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ije\/16.1.98","article-title":"Comparative studies on aetiology and epidemiology of viral conjunctivitis in three countries of East Asia\u2014Japan, Taiwan and South Korea","volume":"16","author":"Ishii","year":"1987","journal-title":"International Journal of Epidemiology"},{"issue":"5126","key":"10.1002\/14651858.CD013520.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bmj.1.5126.873","article-title":"The story of shipyard eye","volume":"1","author":"Jawetz","year":"1959","journal-title":"British Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/ICO.0b013e31820cd607","article-title":"Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis","volume":"30","author":"Jeng","year":"2011","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"100826","DOI":"10.1016\/j.preteyeres.2019.100826","article-title":"Mystery eye: human adenovirus and the enigma of epidemic keratoconjunctivitis","volume":"76","author":"Jonas","year":"2020","journal-title":"Progress in Retinal and Eye Research"},{"issue":"11","key":"10.1002\/14651858.CD013520.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1177\/003591575805101105","article-title":"The clinical features of viral keratitis and a concept of their pathogenesis","volume":"51","author":"Jones","year":"1958","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/bjophthalmol-2014-306508","article-title":"Sensitivity and specificity of the AdenoPlus point-of-care system in detecting adenovirus in conjunctivitis patients at an ophthalmic emergency department: a diagnostic accuracy study","volume":"99","author":"Kam","year":"2015","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajo.2015.12.007","article-title":"A polymerase chain reaction-based algorithm to detect and prevent transmission of adenoviral conjunctivitis in hospital employees","volume":"163","author":"Kuo","year":"2016","journal-title":"American Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaophthalmol.2017.2835","article-title":"Adenoviral conjunctivitis in health care settings: why accurate diagnosis and infection control matter","volume":"135","author":"Kuo","year":"2017","journal-title":"JAMA Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1017\/ice.2018.145","article-title":"Five-year trends in adenoviral conjunctivitis in employees of one medical center","volume":"39","author":"Kuo","year":"2018","journal-title":"Infection Control and Hospital Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamaophthalmol.2021.0150","article-title":"Cost savings from a policy to diagnose and prevent transmission of adenoviral conjunctivitis in employees of a large academic medical center","volume":"139","author":"Kuo","year":"2021","journal-title":"JAMA Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/OPTH.S207976","article-title":"Management of adenoviral keratoconjunctivitis: challenges and solutions","volume":"14","author":"Labib","year":"2020","journal-title":"Clinical Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archopht.1968.00980050469011","article-title":"Community and hospital outbreak of epidemic keratoconjunctivitis","volume":"80","author":"Laibson","year":"1968","journal-title":"Archives of Ophthalmology"},{"issue":"5-6","key":"10.1002\/14651858.CD013520.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/09286586.2018.1509096","article-title":"Seasonal variation in human adenovirus conjunctivitis: a 30-year observational study","volume":"25","author":"Lee","year":"2018","journal-title":"Ophthalmic Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD013520.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jmii.2018.07.005","article-title":"Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children, 2014","volume":"52","author":"Lin","year":"2019","journal-title":"Journal of Microbiology, Immunology, and Infection"},{"issue":"11","key":"10.1002\/14651858.CD013520.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/archopht.1978.03910060465016","article-title":"Corneal histology after epidemic keratoconjunctivitis","volume":"96","author":"Lund","year":"1978","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/jmv.21175","article-title":"Monitoring of adenovirus from conjunctival scrapings in Japan during 2005\u20132006","volume":"80","author":"Matsui","year":"2008","journal-title":"Journal of Medical Virology"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jcrs.2010.06.028","article-title":"Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones","volume":"36","author":"McDonald","year":"2010","journal-title":"Journal of Cataract and Refractive Surgery"},{"issue":"27","key":"10.1002\/14651858.CD013520.pub2-BIB0145|cit145","first-page":"475","article-title":"Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment","volume":"108","author":"Meyer-Rusenberg","year":"2011","journal-title":"Deutsches Arzteblatt International"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0196-6553(98)70035-5","article-title":"Epidemic keratoconjunctivitis outbreak at a tertiary referral eye care clinic","volume":"26","author":"Montessori","year":"1998","journal-title":"American Journal of Infection Control"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1185\/03007990903038269","article-title":"Acute conjunctivitis: truth and misconceptions","volume":"25","author":"O'Brien","year":"2009","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-009-0062-1","article-title":"A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis","volume":"26","author":"Pelletier","year":"2009","journal-title":"Advances in Therapy"},{"issue":"7","key":"10.1002\/14651858.CD013520.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1067\/mic.2002.125193","article-title":"Direct costs associated with a nosocomial outbreak of adenoviral conjunctivitis infection in a long-term care institution","volume":"30","author":"Piednoir","year":"2002","journal-title":"American Journal of Infection Control"},{"issue":"11","key":"10.1002\/14651858.CD013520.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s003470070025","article-title":"Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study","volume":"97","author":"Reinhard","year":"2000","journal-title":"Der Ophthalmologe"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0151|cit151","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2020"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archopht.1996.01100130573014","article-title":"The effects of corticosteroids of adenoviral replication","volume":"114","author":"Romanowski","year":"1996","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00003226-200108000-00020","article-title":"Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit","volume":"20","author":"Romanowski","year":"2001","journal-title":"Cornea"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1167\/iovs.05-1270","article-title":"N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5\/NZW rabbit ocular model","volume":"47","author":"Romanowski","year":"2006","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bjo.69.5.385","article-title":"Prevalence of chlamydial eye infection in patients attending an eye clinic, a VD clinic, and in healthy persons","volume":"69","author":"Ronnerstam","year":"1985","journal-title":"British Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jcjo.2017.12.004","article-title":"Role of the Adenoplus test in refractory, recurrent and clinically undiagnosed conjunctivitis","volume":"53","author":"Sachdev","year":"2018","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ophtha.2018.07.008","article-title":"Outbreak of adenovirus in a neonatal intensive care unit: critical importance of equipment cleaning during inpatient ophthalmologic examinations","volume":"126","author":"Sammons","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0158|cit158","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ophtha.2017.04.034","article-title":"Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network","volume":"124","author":"Shekhawat","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.virol.2015.08.018","article-title":"Recombination of the epsilon determinant and corneal tropism: human adenovirus species D types 15, 29, 56, and 69","volume":"485","author":"Singh","year":"2015","journal-title":"Virology"},{"issue":"8","key":"10.1002\/14651858.CD013520.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archopht.1982.01030040253009","article-title":"Laboratory studies in acute conjunctivitis","volume":"100","author":"Stenson","year":"1982","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0162|cit162","first-page":"2132","article-title":"Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia","volume":"16","author":"Tabbara","year":"2010","journal-title":"Molecular Vision"},{"issue":"9","key":"10.1002\/14651858.CD013520.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/bjo.84.9.968","article-title":"Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1","volume":"84","author":"Uchio","year":"2000","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD013520.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/OPTH.S14282","article-title":"Antiadenoviral effects of N-chlorotaurine in vitro confirmed by quantitative polymerase chain reaction methods","volume":"4","author":"Uchio","year":"2010","journal-title":"Clinical Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD013520.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1442-9071.2010.02457.x","article-title":"Anti-adenoviral effect of interferon-beta and interferon-gamma in serotypes that cause acute keratoconjunctivitis","volume":"39","author":"Uchio","year":"2011","journal-title":"Clinical and Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD013520.pub2-BIB0166|cit166","first-page":"826","article-title":"Simultaneous nosocomial and community outbreak of epidemic keratoconjunctivitis with types 8 and 19 adenovirus","volume":"81","author":"Vastine","year":"1976","journal-title":"Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/160.6.938","article-title":"A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread","volume":"160","author":"Warren","year":"1989","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD013520.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0035-9203(92)90328-A","article-title":"Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan","volume":"86","author":"Woodland","year":"1992","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1002\/14651858.CD013520.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1167\/iovs.12-9656","article-title":"Analysis of human adenovirus type 19 associated with epidemic keratoconjunctivitis and its reclassification as adenovirus type 64","volume":"53","author":"Zhou","year":"2012","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD013520.pub2-BIB0170|cit170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013520","article-title":"Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis","author":"Kuo","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T03:48:35Z","timestamp":1704253715000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013520.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":170,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013520.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]}}}